Cutanea acquisition to bolster Maruho's US presence
This article was originally published in Scrip
Executive Summary
Maruho has acquired 100% of the private US firm Cutanea Life Sciences, apparently taking advantage of the strength of the yen to expand its business interests and capabilities in the US.